PT758252E - Agentes radioterapêuticos contendo estanho-117m - Google Patents

Agentes radioterapêuticos contendo estanho-117m Download PDF

Info

Publication number
PT758252E
PT758252E PT95917088T PT95917088T PT758252E PT 758252 E PT758252 E PT 758252E PT 95917088 T PT95917088 T PT 95917088T PT 95917088 T PT95917088 T PT 95917088T PT 758252 E PT758252 E PT 758252E
Authority
PT
Portugal
Prior art keywords
bone pain
tin
palliation
provides
cancer patients
Prior art date
Application number
PT95917088T
Other languages
English (en)
Inventor
Suresh C Srivastava
George E Meinken
Leonard F Mausner
Harold L Atkins
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of PT758252E publication Critical patent/PT758252E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT95917088T 1994-05-02 1995-04-21 Agentes radioterapêuticos contendo estanho-117m PT758252E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23700394A 1994-05-02 1994-05-02

Publications (1)

Publication Number Publication Date
PT758252E true PT758252E (pt) 2008-12-16

Family

ID=22891937

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95917088T PT758252E (pt) 1994-05-02 1995-04-21 Agentes radioterapêuticos contendo estanho-117m

Country Status (15)

Country Link
US (2) US5853695A (pt)
EP (1) EP0758252B1 (pt)
JP (2) JP3122319B2 (pt)
CN (1) CN1216644C (pt)
AT (1) ATE406918T1 (pt)
AU (1) AU708204B2 (pt)
CA (1) CA2188133C (pt)
DE (1) DE69535828D1 (pt)
DK (1) DK0758252T3 (pt)
ES (1) ES2314977T3 (pt)
HU (1) HU221423B1 (pt)
PT (1) PT758252E (pt)
RU (1) RU2160121C2 (pt)
WO (1) WO1995029706A1 (pt)
ZA (1) ZA953393B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022521A (en) * 1995-05-04 2000-02-08 The Regents Of The University Of Michigan Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease
US6231832B1 (en) * 1998-03-23 2001-05-15 Brookhaven Science Associates Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use
US6004532A (en) * 1998-06-08 1999-12-21 Brookhaven Science Associates Formulation for Tin-117m /diethylenetriaminepentaacetic acids
US6680993B2 (en) 1999-11-30 2004-01-20 Stanley Satz Method of producing Actinium-225 and daughters
US6641820B1 (en) * 2000-01-19 2003-11-04 Allergan, Inc. Clostridial toxin derivatives and methods to treat pain
US6500436B2 (en) 2000-01-19 2002-12-31 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
US7138127B1 (en) 2000-01-19 2006-11-21 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
US7112570B2 (en) * 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
US6541514B2 (en) 2001-05-02 2003-04-01 Brookhaven Science Associates, Llc Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
RU2313838C1 (ru) * 2006-12-29 2007-12-27 Институт ядерных исследований РАН ИЯИ РАН Способ получения радиоолова в состоянии без носителя и мишень для его осуществления (варианты)
EP2214696A1 (en) * 2007-10-23 2010-08-11 Allergan, Inc. Methods of treating chronic neurogenic inflammation using modified clostridial toxins
EP2545560B1 (en) * 2010-03-10 2014-01-22 The South African Nuclear Energy Corporation Limited Method of producing radionuclides
WO2013096776A2 (en) 2011-12-21 2013-06-27 Iso Therapeutics Group Llc Radioactive compositions and methods for their therapeutic use
RU2533267C1 (ru) * 2013-10-07 2014-11-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО ТГМУ Минздрава России) Способ фотон-захватной терапии опухолей
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
JP6930922B2 (ja) * 2015-05-25 2021-09-01 アイジーエル ファーマ，インコーポレイティド 放射性同位体用ｄｏｔｍｐキット製剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533541A (en) * 1983-08-25 1985-08-06 The United States Of America As Represented By The United States Department Of Energy Tin-117m-labeled stannic (Sn4+) chelates

Also Published As

Publication number Publication date
DE69535828D1 (de) 2008-10-16
ATE406918T1 (de) 2008-09-15
US6517810B1 (en) 2003-02-11
HU9603039D0 (en) 1997-01-28
WO1995029706A1 (en) 1995-11-09
AU2391495A (en) 1995-11-29
JPH08208528A (ja) 1996-08-13
CA2188133C (en) 2000-08-08
CN1216644C (zh) 2005-08-31
ES2314977T3 (es) 2009-03-16
ZA953393B (en) 1996-02-09
HUT75311A (en) 1997-05-28
CA2188133A1 (en) 1995-11-09
JP3122319B2 (ja) 2001-01-09
CN1149836A (zh) 1997-05-14
DK0758252T3 (da) 2009-01-05
EP0758252A1 (en) 1997-02-19
HU221423B1 (en) 2002-09-28
AU708204B2 (en) 1999-07-29
EP0758252B1 (en) 2008-09-03
RU2160121C2 (ru) 2000-12-10
US5853695A (en) 1998-12-29
JPH07309783A (ja) 1995-11-28

Similar Documents

Publication Publication Date Title
HU9603039D0 (en) Tin-117m-containing radiotherapeutic agents
PL299814A1 (en) Pharmaceutical preparation inhibiting depletion of human bone tissue
IL133585A0 (en) Soluble prodrugs of paclitaxel
MX9700081A (es) Composiciones farmaceuticas de tacrina.
UA70942C2 (uk) Застосування n-заміщеного індоліл-3-гліоксиламіду як протипухлинного засобу, спосіб лікування пухлинних захворювань та лікарська композиція для лікування пухлинних захворювань
SG166294G (en) Inhalation medicaments for treating respiratory disorders
HU9502193D0 (en) Combination treatment for inhibiting bone loss
HK1022437A1 (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
EP0777484A4 (en) INTRAVENOUS ALENDRONATE FORMULATIONS
MXPA04003674A (es) Uso mejorado de compuesto antitumoral en terapia de cancer.
RU96123126A (ru) Агенты для лучевой терапии, содержащие олово-117m
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
ES2135342A1 (es) Procedimiento para prevenir el cancer de mama.
GB9103764D0 (en) Compositions
DE3474774D1 (en) Therapeutic compositions for oral use containing stable s-adenosy1-l-methionine salts
NZ326345A (en) Composition containing diosgenin
FR2500303B1 (pt)
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
EP0588477A3 (en) Medicinal composition comprising tcf-ii
EP1150703A4 (en) CHAPERONIN 10 AND BETA INTERFERON THERAPY FOR MULTIPLE Sclerosis
MX9702671A (es) Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados.
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
UA10301A (uk) Спосіб лікуваhhя раку шлуhку
UA28644A (uk) Спосіб лікування первинної аменореї центрального генезу у дівчат-підлітків
UA30251A (uk) Спосіб лікування гіпертонії сфінктера одді у хворих на хронічний безкам'яний холецистит при поєднанні з підвищенням тонусу симпатичної нервової системи